IL-15 PROCYTOKINE ANTIBODY FUSION PROTEINS
Provided are activatable proprotein homodimers comprising two separate but identical polypeptide chains, each chain comprising a fragment antigen-binding (Fab) region that specifically binds to human PD-1 or human PD-L1 or human B7H3, a hinge/Fc domain, a linker, an IL-15 protein, a protease cleavable linker, and an IL-15Rα protein. Also provided are related pharmaceutical compositions and methods of use thereof..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Europäisches Patentamt - (2024) vom: 07. März Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
LI ZIJUAN [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-03-07, Last update posted on www.tib.eu: 2024-04-10, Last updated: 2024-04-19 |
---|
Patentnummer: |
WO2024047585 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA001133497 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA001133497 | ||
003 | DE-627 | ||
005 | 20240419122441.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240322s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA001133497 | ||
035 | |a (EPA)WO2024047585 | ||
035 | |a (EPA)90100493 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a LI ZIJUAN |e verfasserin |4 aut | |
245 | 1 | 0 | |a IL-15 PROCYTOKINE ANTIBODY FUSION PROTEINS |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2024-03-07, Last update posted on www.tib.eu: 2024-04-10, Last updated: 2024-04-19 | ||
520 | |a Provided are activatable proprotein homodimers comprising two separate but identical polypeptide chains, each chain comprising a fragment antigen-binding (Fab) region that specifically binds to human PD-1 or human PD-L1 or human B7H3, a hinge/Fc domain, a linker, an IL-15 protein, a protease cleavable linker, and an IL-15Rα protein. Also provided are related pharmaceutical compositions and methods of use thereof. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a ZHANG FEIFEI |e verfasserin |4 aut | |
700 | 0 | |a ZHANG ZE |e verfasserin |4 aut | |
700 | 0 | |a ZHOU HONGXING |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 07. März |
773 | 1 | 8 | |g year:2024 |g day:07 |g month:03 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/90100493/publication/WO2024047585A1?q=WO2024047585 |x 0 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2024 |b 07 |c 03 |